VEGFA and lung carcinoma: The same bisbibenzyl (9) inhibited the proliferation of HUVECs (human umbilical vascular endothelial cells), decreased mortality and migration of HEVECs and vascular endothelial growth factor (VEGF) against human lung cancer H460 cell lines [119].